Hostname: page-component-8448b6f56d-xtgtn Total loading time: 0 Render date: 2024-04-16T13:49:25.247Z Has data issue: false hasContentIssue false
  • English
  • Français

Suppression of Eating by Fenfluramine in Patients with Bulimia Nervosa

Published online by Cambridge University Press:  29 January 2018

P. H. Robinson ,
S. A. Checkley  and
G. F. M. Russell
P. H. Robinson
Affiliation:
Institute of Psychiatry, De Crespigny Park, London SE5 8AF
S. A. Checkley
Affiliation:
Maudsley Hospital, London
G. F. M. Russell
Affiliation:
Institute of Psychiatry and The Maudsley Hospital, London
Get access Rights & Permissions [Opens in a new window]

Summary

Fifteen patients with bulimia nervosa received fenfluramine (60 mg po) or placebo under double-blind, randomly ordered conditions. Two hours later food was presented. Significantly less food was eaten after fenfluramine and the quantity eaten was inversely correlated with serum fenfluramine levels. Significantly fewer patients reported bulimic symptoms during the test after fenfluramine, but no significant effect was demonstrated after leaving the ward. Fenfluramine caused drowsiness but did not reduce hunger ratings. Similarly, eating failed to reduce hunger ratings normally in the patients. These findings suggest that in patients with bulimia nervosa, hunger is reported abnormally and eating is suppressed by fenfluramine. Bulimic symptoms were probably reduced by fenfluramine, which may prove to be a useful treatment for bulimia nervosa.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 146 , Issue 2 , February 1985 , pp. 169 - 176
Copyright
Copyright © 1985 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 3rd edition. Washington DC: American Psychiatric Association, 1980 Google Scholar
Andersen, A. E. (1983) Anorexia nervosa and bulimia. A spectrum of eating disorders. Journal of Adolescent Health Care, 4, 15–21.CrossRefGoogle ScholarPubMed
Blundell, J. E., Latham, C. J., Moniz, E., McArthur, R. A. & Rogers, P. J. (1979) Structural analysis of the actions of amphetamine and fenfluramine on food intake and feeding behaviour in animals and man. Current Medical Research and Opinion, 6, Supplement 1, 34–54.Google Scholar
Campbell, D. B. (1971) Plasma concentrations of fenfluramine and its metabolite, norfenfluramine, after single and repeated oral administration. British Journal of Pharmacology, 43, 465P–466P.Google Scholar
Connell, P. H. (1958) Amphetamine Psychosis. Maudsley Monograph No 5, Oxford University Press, London.Google Scholar
Connell, P. H. (1975) Central nervous system stimulants. In Mayler's Side Effects of Drugs (Ed. Dukes, M. N.) Excerpta Medica: Amsterdam, Oxford.Google Scholar
Connell, P. H. (1979) Drug dependence liability of anorectic drugs: a clinical viewpoint with particular reference to fenfluramine. Current Medical Research and Opinion 6, Supplement 1, 153–159.CrossRefGoogle Scholar
Documenta Geigy (1959) Scientific Tables, 7th Edition. (Eds. Diem, K. and Lentner, C.).Google Scholar
Fairburn, C. (1981) A cognitive behavioural approach to the treatment of bulimia. Psychological Medicine 11, 707–711.Google Scholar
Fairburn, C. (1982) Binge eating and bulimia nervosa. Smith, Kline & French Publications 1, No 4, Welwyn Garden City, Hertfordshire.Google Scholar
Garfinkel, P. E. (1974) Perception of hunger and satiety in anorexia nervosa. Psychological Medicine 4, 309–315.Google Scholar
Garfinkel, P. E., Moldofsky, H. & Garner, D. M. (1980) The heterogeneity of anorexia nervosa: bulimia as a distinct subgroup. Archives of General Psychiatry, 37, 1036–1040.Google Scholar
Garner, D. M. & Garfinkel, P. E. (1979) The Eating Attitudes Test: an index of the symptoms of anorexia nervosa. Psychological Medicine 9, 273–279.CrossRefGoogle ScholarPubMed
Green, R. S. & Rau, J. H. (1974) Treatment of compulsive eating disturbances with anticonvulsant medication. American Journal of Psychiatry 131, 428–432.Google Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.Google Scholar
Hays, W. L. (1973) Statistics for the Social Sciences New York: Holt, Rinehart & Winston.Google Scholar
Kyriakides, M. & Silversione, T. (1979) Comparison of the effects of d-amphetamine and fenfluramine on hunger and food intake in man. Neuropharmacology 18, 1007–1008.Google Scholar
Kyriakides, M. & Silversione, T. & (1979) A double blind comparison of fenfluramine and dextroamphetamine on feeding behaviour in man. Current Medical Research and Opinion 6, Supplement 1, 180–187.CrossRefGoogle Scholar
Ong, Y. L., Checkley, S. A. & Russell, G. F. M. (1983) Suppression of bulimic symptoms with methylamphetamine. British Journal of Psychiatry, 143, 288–293.Google Scholar
Pope, H. G., Hudson, J. I., Jonas, J. M. & Yurgelun-Todd, D. (1983) Bulimia treated with imipramine: a placebo controlled, double blind study. American Journal of Psychiatry, 140, 554–558.Google ScholarPubMed
Robinson, R. G., Tortosa, M., Sullivan, J., Buchanan, E., Andersen, A. E. & Folstein, M. F. (1983) Quantitative assessment of psychologic state of patients with anorexia nervosa or bulimia: response to caloric stimulus. Psychosomatic Medicine, 45, 283–292.Google Scholar
Russell, G. F. M. (1977) The present status of anorexia nervosa. Psychological Medicine, 7, 363–367.Google Scholar
Russell, G. F. M. (1979) Bulimia nervosa, an ominous variant of anorexia nervosa. Psychological Medicine, 9, 429–448.Google Scholar
Sabine, E. J., Yonace, A., Farrington, A. J., Barratt, K. H., & Wakeling, A. (1983) Bulimia nervosa: a placebo controlled, double blind therapeutic trial of mianserin. British Journal of Clinical Pharmacology, 15, 1955–2025.Google Scholar
Silverstone, T., Fincham, J. & Campbell, D. B. (1975) The anorectic activity of fenfluramine. Postgraduate Medical Journal, 51, Supplement 1, 171–174.Google ScholarPubMed
Silverstone, T., Fincham, J. (1978) Experimental techniques for measurement of hunger and food intake in man. In Central Mechanisms of Anorectic Drugs, (eds. Garattini, S. & Samanin, R.). New York: Raven Press.Google Scholar
Stunkard, A. J. (1959) Eating patterns and obesity. Psychiatric Quarterly, 33, 284–292.Google Scholar
Stunkard, A. J., Rickels, J. & Hesbacher, P (1973) Fenfluramine in the treatment of obesity. Lancet i, 503–505.CrossRefGoogle Scholar
Walsh, B. T., Stewart, J. W., Wright, L., Harrison, W., Roose, S. P. & Glassman, A. H. (1982) Treatment of bulimia with monoamine oxidase inhibitors. American Journal of Psychiatry, 139, 1629–1630.Google ScholarPubMed
Wardle, J. (1980) Dietary restraint and binge eating. Behavioural Analysis and Modification, 4, 201–209.Google Scholar
Wermuth, B. M., Davis, K. L., Hollister, L. E. & Stunkard, A. J. (1977) Phenytoin treatment of the binge eating syndrome. American Journal of Psychiatry, 134, 1249–1253.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.